China's First CAR-T, World's First Solid-Tumor CAR-T
Cell Therapy · CAR-T
Fosun Pharma developed Yikaida® (Axicabtagene Ciloleucel) — China's first approved CAR-T — and brought Kailimei® (CT041), the world's first solid-tumor CAR-T, into clinical use at Fosun Health hospitals for advanced gastric and gastroesophageal cancers.